April 6, 2020
Towa Pharmaceutical, one of Japan’s Big Three generic makers, is curbing its shipments for the hypertension medicine valsartan and its combination drugs as it has been unable to secure API supplies from India amid the COVID-19 pandemic. In its notification...read more